OESOPHAGEAL SQUAMOUS CELL CARCINOMA RECURRENT

This adverse event was reported 12 times

OESOPHAGEAL SQUAMOUS CELL CARCINOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SELEGILINE HYDROCHLORIDE 1 0.0017
1 LEMBOREXANT 1 0.0003
2 VONOPRAZAN FUMARATE 1 0.0001
3 CISPLATIN 6 0.0001
4 NIVOLUMAB 5 0.0001
5 SODIUM BICARBONATE INJECTION, 1 0.0000
6 PIPERACILLIN SODIUM,TAZOBACTAM SODIUM 1 0.0000
7 DOCETAXEL ANHYDROUS 2 0.0000
8 DOCETAXEL 2 0.0000
9 FLUOROURACIL CREAM, 0.5% 2 0.0000
See all drugs enriched for association with OESOPHAGEAL SQUAMOUS CELL CARCINOMA RECURRENT